Vifor (International) AG
St. Gallen, SG
- UEI
- R77QQUHCTUP7
- CAGE
- SDVD5
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- International Organization
- SAM.gov registration date
- Physical address
- Rechenstrasse 37, 9014 St. Gallen, Switzerland
- Website
- viforpharma.com
- Founded
- 1927
- Employees
- 1K-5K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $6,550 |
| FY2025 | -$13,516 |
| FY2024 | $46,712 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $6,550 |
Contract vehicles
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Travere Therapeutics, Inc. | San Diego, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Kiniksa Pharmaceuticals (Uk), LTD. | England | 325412 Pharmaceutical Preparation Manufacturing |
| United Therapeutics Corp | Silver Spring, MD | 325412 Pharmaceutical Preparation Manufacturing |
| Otsuka America Pharmaceutical Inc. | Rockville, MD | 325412 Pharmaceutical Preparation Manufacturing |
| Mckesson Plasma And Biologics LLC | Shepherdsville, KY | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Vifor (International) AG, a Swiss-based foreign-owned pharmaceutical manufacturer, supplies specialized anemia, nephrology, and pruritus treatments to the Department of Veterans Affairs as a prime contractor exclusively through the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and related blanket purchase agreements. The company competes on full-and-open awards without set-asides; all 22 prime awards in the recent footprint are unrestricted competition.
Vifor's federal capability portfolio centers on four core pharmaceutical products for veteran healthcare. MIRCERA (methoxy polyethylene glycol-epoetin beta), an anemia treatment, anchors the largest contract vehicle — a $23.8 million blanket purchase agreement with the VA National Acquisition Center running through June 2026. KORSUVA (difelikefalin), a pruritus treatment, is covered under a $150,000 single-award BPA also held through June 2026. KRYSTEXXA (pegloticase) for gout treatment and related pharmaceutical formulations round out the active supply set. Recent delivery-order work includes a $2,730 order from Veterans Integrated Service Network 21 for MIRCERA 120 MCG syringes (April 2026), a $11,310 KORSUVA delivery order from VISN 20 (April 2024), and a $3,678 KRYSTEXXA 8 MG order from VISN 5 (May 2024). Vifor also holds a new $750,000 Federal Supply Schedule contract awarded by VISN 12 effective May 1, 2026, through April 30, 2031, covering the same pharmaceutical product line.
Customer concentration is absolute — 100% of awards fund VA programs across five distinct Veterans Integrated Service Networks. The VA National Acquisition Center holds the two largest vehicles by potential value ($24 million combined), while VISN 12, VISN 21, VISN 5, and VISN 20 place individual small-dollar delivery orders. The distinction between the two rankings is stark: the National Acquisition Center's two blanket purchase agreements dwarf the 20 delivery orders issued by field VISNs, which individually range from $65 to $11,310. Activity accelerated sharply in 2024 (12 awards) after minimal prior volume (2 awards in 2020, 1 in 2023), with 3 awards in 2025 and 3 in 2026. Only one award ($3,000 in combined potential value) reaches completion within the next twenty-four months, indicating stable recompete exposure through 2026 for the two major BPAs. Vifor operates as a pure prime contractor with no subcontract footprint in the federal government. Place of performance spans multiple VA facilities nationwide with administrative coordination through the Pharmaceuticals and Drugs FSS-61-IB schedule.
Quick answers
Is Vifor (International) AG registered in SAM.gov?
Yes. Vifor (International) AG's SAM.gov registration is active through October 16, 2027.
What is Vifor (International) AG's CAGE code?
Vifor (International) AG's CAGE code is SDVD5, and its Unique Entity ID (UEI) is R77QQUHCTUP7.
Which contract vehicles does Vifor (International) AG hold?
Vifor (International) AG holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has Vifor (International) AG received in federal contracts?
Federal contracts obligated $39,746 to Vifor (International) AG in fiscal years 2023 through 2027.
What is Vifor (International) AG's most recent federal award?
Vifor (International) AG's most recent federal contract award is Korsuva (DIFELIKEFALIN) (36C25226N0475), from Veterans Integrated Service Network 12 (VHA), on July 2, 2026.
On GovTribe
See Vifor (International) AG's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors